INFINITT Healthcare Co. Ltd
INFINITT Healthcare Co., Ltd. provides imaging IT solutions worldwide. Its products include INFINITT PACS, a picture archiving and communication systems for radiologists; INFINITT RIS, a radiology information solution; INFINITT Healthcare Analytics - Enterprise Search, a data analytics solution that enchances diagnostics accuracy; INFINITT DoseM, a radiation dose management solution; INFINITT Rep… Read more
INFINITT Healthcare Co. Ltd (071200) - Net Assets
Latest net assets as of June 2025: ₩180.88 Billion KRW
Based on the latest financial reports, INFINITT Healthcare Co. Ltd (071200) has net assets worth ₩180.88 Billion KRW as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩229.14 Billion) and total liabilities (₩48.26 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩180.88 Billion |
| % of Total Assets | 78.94% |
| Annual Growth Rate | 10.02% |
| 5-Year Change | 95.16% |
| 10-Year Change | 186.2% |
| Growth Volatility | 10.8 |
INFINITT Healthcare Co. Ltd - Net Assets Trend (2011–2024)
This chart illustrates how INFINITT Healthcare Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for INFINITT Healthcare Co. Ltd (2011–2024)
The table below shows the annual net assets of INFINITT Healthcare Co. Ltd from 2011 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩177.91 Billion | +32.76% |
| 2023-12-31 | ₩134.01 Billion | +16.40% |
| 2022-12-31 | ₩115.13 Billion | +1.31% |
| 2021-12-31 | ₩113.64 Billion | +24.66% |
| 2020-12-31 | ₩91.16 Billion | +7.72% |
| 2019-12-31 | ₩84.63 Billion | +9.51% |
| 2018-12-31 | ₩77.28 Billion | +9.11% |
| 2017-12-31 | ₩70.83 Billion | +1.60% |
| 2016-12-31 | ₩69.71 Billion | +12.15% |
| 2015-12-31 | ₩62.16 Billion | +10.89% |
| 2014-12-31 | ₩56.06 Billion | +4.69% |
| 2013-12-31 | ₩53.55 Billion | +18.49% |
| 2012-12-31 | ₩45.19 Billion | -12.12% |
| 2011-12-31 | ₩51.42 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to INFINITT Healthcare Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 9704.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩133.76 Billion | 75.19% |
| Common Stock | ₩12.20 Billion | 6.86% |
| Other Components | ₩31.95 Billion | 17.96% |
| Total Equity | ₩177.91 Billion | 100.00% |
INFINITT Healthcare Co. Ltd Competitors by Market Cap
The table below lists competitors of INFINITT Healthcare Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Vakko Tekstil ve Hazir Giyim Sanayi Isletmeleri AS
IS:VAKKO
|
$53.10 Million |
|
Forth Smart Service Public Company Limited
BK:FSMART
|
$53.11 Million |
|
RENERGEN LTD CDI/1:1
F:996
|
$53.11 Million |
|
Canadian Gold Corp.
F:8S8
|
$53.11 Million |
|
Thermaltake Technology Co Ltd
TWO:3540
|
$53.09 Million |
|
Esso (Thailand) Public Company Limited
BK:BSRC
|
$53.08 Million |
|
Textainer Group Holdings Limited
OTCQX:TGHLF
|
$53.08 Million |
|
Yong Pyong Resort Corp
KO:070960
|
$53.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in INFINITT Healthcare Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 134,013,060,780 to 177,909,353,070, a change of 43,896,292,290 (32.8%).
- Net income of 43,923,371,920 contributed positively to equity growth.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩43.92 Billion | +24.69% |
| Other Changes | ₩-27.08 Million | -0.02% |
| Total Change | ₩- | 32.76% |
Book Value vs Market Value Analysis
This analysis compares INFINITT Healthcare Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.80x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 2.05x to 0.80x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩2859.93 | ₩5860.00 | x |
| 2017-12-31 | ₩2905.55 | ₩5860.00 | x |
| 2018-12-31 | ₩3170.27 | ₩5860.00 | x |
| 2019-12-31 | ₩3471.78 | ₩5860.00 | x |
| 2020-12-31 | ₩3739.72 | ₩5860.00 | x |
| 2021-12-31 | ₩4661.97 | ₩5860.00 | x |
| 2022-12-31 | ₩4722.98 | ₩5860.00 | x |
| 2023-12-31 | ₩5497.64 | ₩5860.00 | x |
| 2024-12-31 | ₩7298.41 | ₩5860.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently INFINITT Healthcare Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 24.69%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 43.24%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 1.31x
- Recent ROE (24.69%) is above the historical average (10.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 16.71% | 12.89% | 0.85x | 1.53x | ₩3.59 Billion |
| 2014 | 3.92% | 3.52% | 0.80x | 1.40x | ₩-3.43 Billion |
| 2015 | 9.10% | 9.15% | 0.75x | 1.33x | ₩-561.45 Million |
| 2016 | 10.19% | 9.94% | 0.79x | 1.30x | ₩134.67 Million |
| 2017 | 2.18% | 2.12% | 0.81x | 1.27x | ₩-5.54 Billion |
| 2018 | 6.38% | 7.67% | 0.69x | 1.20x | ₩-2.80 Billion |
| 2019 | 8.56% | 9.76% | 0.70x | 1.26x | ₩-1.22 Billion |
| 2020 | 7.33% | 9.54% | 0.59x | 1.31x | ₩-2.43 Billion |
| 2021 | 19.94% | 28.98% | 0.54x | 1.27x | ₩11.29 Billion |
| 2022 | 0.11% | 0.15% | 0.59x | 1.30x | ₩-11.38 Billion |
| 2023 | 14.28% | 21.63% | 0.51x | 1.31x | ₩5.74 Billion |
| 2024 | 24.69% | 43.24% | 0.44x | 1.31x | ₩26.13 Billion |
Industry Comparison
This section compares INFINITT Healthcare Co. Ltd's net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.
Industry Context
- Industry: Healthcare Equipment & Supplies
- Average net assets among peers: $93,492,014,156
- Average return on equity (ROE) among peers: -8.08%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| INFINITT Healthcare Co. Ltd (071200) | ₩180.88 Billion | 16.71% | 0.27x | $53.10 Million |
| InBody Co.Ltd (041830) | $183.73 Billion | 18.52% | 0.11x | $208.16 Million |
| MEDIANA Co.Ltd (041920) | $34.91 Billion | 20.29% | 0.27x | $70.69 Million |
| Value Added Technology Co. Ltd (043150) | $349.29 Billion | 22.01% | 0.46x | $109.99 Million |
| MEKICS Co Ltd (058110) | $7.87 Billion | -24.74% | 1.89x | $14.44 Million |
| Meta Biomed Co. Ltd (059210) | $39.05 Billion | 3.02% | 0.38x | $50.83 Million |
| i-SENS Inc (099190) | $118.81 Billion | 12.18% | 0.38x | $127.37 Million |
| Sewoon Medical Co. Ltd (100700) | $46.71 Billion | 7.88% | 0.18x | $34.07 Million |
| CU Medical Systems Inc (115480) | $58.36 Billion | 16.15% | 0.51x | $14.81 Million |
| PeopleBio Inc (304840) | $2.70 Billion | -148.07% | 0.61x | $5.72 Million |